GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (STU:29A) » Definitions » Shiller PE Ratio

Amphastar Pharmaceuticals (STU:29A) Shiller PE Ratio : 54.73 (As of Sep. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Amphastar Pharmaceuticals Shiller PE Ratio?

As of today (2024-09-21), Amphastar Pharmaceuticals's current share price is €43.78. Amphastar Pharmaceuticals's E10 for the quarter that ended in Jun. 2024 was €0.80. Amphastar Pharmaceuticals's Shiller PE Ratio for today is 54.73.

The historical rank and industry rank for Amphastar Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

STU:29A' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.35   Med: 56.33   Max: 114.2
Current: 57.74

During the past years, Amphastar Pharmaceuticals's highest Shiller PE Ratio was 114.20. The lowest was 14.35. And the median was 56.33.

STU:29A's Shiller PE Ratio is ranked worse than
83.12% of 468 companies
in the Drug Manufacturers industry
Industry Median: 23.995 vs STU:29A: 57.74

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2024 was €0.678. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.80 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amphastar Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Amphastar Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Shiller PE Ratio Chart

Amphastar Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 46.40 89.92

Amphastar Pharmaceuticals Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.80 70.52 89.92 55.85 46.09

Competitive Comparison of Amphastar Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amphastar Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Shiller PE Ratio falls into.



Amphastar Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amphastar Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=43.78/0.8
=54.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amphastar Pharmaceuticals's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.678/132.5538*132.5538
=0.678

Current CPI (Jun. 2024) = 132.5538.

Amphastar Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 -0.093 100.428 -0.123
201412 -0.049 99.070 -0.066
201503 -0.009 99.621 -0.012
201506 -0.134 100.684 -0.176
201509 -0.062 100.392 -0.082
201512 0.156 99.792 0.207
201603 0.045 100.470 0.059
201606 0.134 101.688 0.175
201609 0.071 101.861 0.092
201612 -0.057 101.863 -0.074
201703 0.019 102.862 0.024
201706 0.036 103.349 0.046
201709 0.002 104.136 0.003
201712 0.025 104.011 0.032
201803 -0.122 105.290 -0.154
201806 -0.051 106.317 -0.064
201809 0.043 106.507 0.054
201812 0.035 105.998 0.044
201903 0.018 107.251 0.022
201906 0.850 108.070 1.043
201909 0.027 108.329 0.033
201912 -0.018 108.420 -0.022
202003 0.072 108.902 0.088
202006 -0.004 108.767 -0.005
202009 0.068 109.815 0.082
202012 -0.107 109.897 -0.129
202103 0.084 111.754 0.100
202106 0.133 114.631 0.154
202109 0.502 115.734 0.575
202112 0.345 117.630 0.389
202203 0.427 121.301 0.467
202206 0.312 125.017 0.331
202209 0.303 125.227 0.321
202212 0.623 125.222 0.659
202303 0.467 127.348 0.486
202306 0.452 128.729 0.465
202309 0.853 129.860 0.871
202312 0.624 129.419 0.639
202403 0.745 131.776 0.749
202406 0.678 132.554 0.678

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amphastar Pharmaceuticals  (STU:29A) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amphastar Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amphastar Pharmaceuticals Business Description

Traded in Other Exchanges
Address
11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals Headlines

No Headlines